Literature DB >> 10642173

Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo.

S D Briggs1, E C Lerner, T E Smithgall.   

Abstract

Nef is an HIV accessory protein required for high-titer viral replication and AIDS progression. Previous studies have shown that the SH3 domains of Hck and Lyn bind to Nef via proline-rich sequences in vitro, identifying these Src-related kinases as potential targets for Nef in vivo. Association of Nef with Hck causes displacement of the intramolecular interaction between the SH3 domain and the SH2-kinase linker, leading to kinase activation both in vitro and in vivo. In this study, we investigated whether interaction with Nef induces activation of other Src family kinases (Lyn, Fyn, Src, and Lck) following coexpression with Nef in Rat-2 fibroblasts. Coexpression with Nef induced Hck kinase activation and fibroblast transformation, consistent with previous results. In contrast, coexpression of Nef with Lyn was without effect, despite equivalent binding of Nef to full-length Lyn and Hck. Furthermore, Nef was found to suppress the kinase and transforming activities of Fyn, the SH3 domain of which exhibits low affinity for Nef. Coexpression with Nef did not alter c-Src or Lck tyrosine kinase or transforming activity in this system. Differential modulation of Src family members by Nef may produce unique downstream signals depending on the profile of Src kinases expressed in a given cell type.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642173     DOI: 10.1021/bi992504j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Altered dynamics in Lck SH3 upon binding to the LBD1 domain of Herpesvirus saimiri Tip.

Authors:  David D Weis; Peter Kjellen; Bartholomew M Sefton; John R Engen
Journal:  Protein Sci       Date:  2006-10       Impact factor: 6.725

Review 2.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

3.  HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.

Authors:  Ronald P Trible; Lori Emert-Sedlak; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2006-07-18       Impact factor: 5.157

4.  State and role of SRC family kinases in replication of herpes simplex virus 1.

Authors:  Yu Liang; Bernard Roizman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Chimeric SCID-hu Model as a Human Hematopoietic Stem Cell Host That Recapitulates the Effects of HIV-1 on Bone Marrow Progenitors in Infected Patients.

Authors:  I Birgitta Sundell; Prasad S Koka
Journal:  J Stem Cells       Date:  2006

6.  The expression of HIV-1 tat and nef genes induces cell-specific changes in growth properties and morphology of different types of rat cells.

Authors:  Irina Shugurova; Irina Bobrisheva; Irina Surkova; Igor Grivennikov; Vyacheslav Tarantul
Journal:  Cell Prolif       Date:  2002-08       Impact factor: 6.831

7.  HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenon.

Authors:  Alyssa Cornall; Johnson Mak; Alison Greenway; Gilda Tachedjian
Journal:  Viruses       Date:  2013-09-18       Impact factor: 5.048

Review 8.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

9.  Differential sensitivity of Src-family kinases to activation by SH3 domain displacement.

Authors:  Jamie A Moroco; Jodi K Craigo; Roxana E Iacob; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

10.  HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway.

Authors:  S D Briggs; B Scholtz; J M Jacque; S Swingler; M Stevenson; T E Smithgall
Journal:  J Biol Chem       Date:  2001-04-27       Impact factor: 5.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.